Mettler-Toledo International Inc. (MTD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 1.20B USD | Liabilities, Current |
| Cash and equivalents | 51.38M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 731.48M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 411.56M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.20B | $51.38M | (m) | $731.48M | $411.56M | (m) |
| 2026-03-31 | (m) | $1.11B | (m) | (m) | $708.21M | $404.83M | (m) |
| 2025-12-31 | (m) | $1.20B | (m) | (m) | $778.24M | $387.23M | (m) |
| 2025-09-30 | (m) | $1.19B | $69.06M | (m) | $687.26M | $401.81M | (m) |
| 2025-06-30 | (m) | $1.11B | $61.83M | (m) | $681.60M | $388.08M | (m) |
| 2025-03-31 | (m) | $1.15B | (m) | (m) | $638.39M | $358.79M | (m) |
| 2024-12-31 | (m) | $1.17B | (m) | (m) | $687.11M | $342.27M | (m) |
| 2024-09-30 | (m) | $1.18B | $71.57M | (m) | $637.20M | $375.81M | (m) |
| 2024-06-30 | (m) | $1.28B | $70.81M | (m) | $634.71M | $366.39M | (m) |
| 2024-03-31 | (m) | $1.13B | (m) | (m) | $650.33M | $373.67M | (m) |
| 2023-12-31 | (m) | $1.18B | $69.81M | (m) | $663.89M | $385.87M | (m) |
| 2023-09-30 | (m) | $1.07B | $69.67M | (m) | $634.97M | $375.96M | (m) |
| 2023-06-30 | (m) | $1.01B | $83.57M | (m) | $648.00M | $394.96M | (m) |
| 2023-03-31 | (m) | $1.00B | (m) | (m) | $640.05M | $427.55M | (m) |
| 2022-12-31 | (m) | $1.15B | $95.97M | (m) | $709.32M | $441.69M | (m) |
| 2022-09-30 | (m) | $1.16B | $122.14M | (m) | $611.40M | $451.32M | (m) |
| 2022-06-30 | (m) | $1.12B | $109.45M | (m) | $626.59M | $463.32M | (m) |
| 2022-03-31 | (m) | $1.09B | (m) | (m) | $617.88M | $446.49M | (m) |
| 2021-12-31 | (m) | $1.15B | $98.56M | (m) | $647.34M | $414.54M | (m) |
| 2021-09-30 | (m) | $1.00B | $183.67M | (m) | $603.36M | $381.46M | (m) |
| 2021-06-30 | (m) | $938.37M | $142.25M | (m) | $600.19M | $350.16M | (m) |
| 2021-03-31 | (m) | $841.81M | $106.65M | (m) | $574.42M | $321.34M | (m) |
| 2020-12-31 | (m) | $840.33M | $94.25M | (m) | $593.81M | $297.61M | (m) |
| 2020-09-30 | (m) | $764.08M | $153.69M | (m) | $521.78M | $292.33M | (m) |
| 2020-06-30 | (m) | $702.83M | $127.28M | (m) | $490.43M | $299.75M | (m) |
| 2020-03-31 | (m) | $679.84M | $323.58M | (m) | $518.56M | $292.11M | (m) |
| 2019-12-31 | (m) | $754.51M | $207.78M | (m) | $566.26M | $274.29M | (m) |
| 2019-09-30 | (m) | $719.25M | $120.53M | (m) | $503.25M | $280.98M | (m) |
| 2019-06-30 | (m) | $707.25M | $124.44M | (m) | $498.72M | $286.35M | (m) |
| 2019-03-31 | (m) | $707.96M | $126.48M | (m) | $489.28M | $282.09M | (m) |
| 2018-12-31 | (m) | $734.43M | $178.11M | (m) | $535.53M | $268.82M | (m) |
| 2018-09-30 | (m) | $697.47M | $137.45M | (m) | $494.89M | $277.27M | (m) |
| 2018-06-30 | (m) | $688.82M | $183.19M | (m) | $486.20M | $270.05M | (m) |
| 2018-03-31 | (m) | $636.88M | $98.95M | (m) | $483.92M | $278.32M | (m) |
| 2017-12-31 | (m) | $689.67M | $148.69M | (m) | $528.62M | $255.39M | (m) |
| 2017-09-30 | (m) | $652.36M | $169.09M | (m) | $483.17M | $263.53M | (m) |
| 2017-06-30 | (m) | $588.81M | $146.33M | (m) | $448.10M | $253.73M | (m) |
| 2017-03-31 | (m) | $561.16M | $164.89M | (m) | $439.41M | $242.38M | (m) |
| 2016-12-31 | (m) | $587.51M | $158.67M | (m) | $454.99M | $222.05M | (m) |
| 2016-09-30 | (m) | $620.85M | $146.13M | (m) | $414.61M | $239.99M | (m) |
| 2016-06-30 | (m) | $591.11M | $114.65M | (m) | $407.97M | $234.01M | (m) |
| 2016-03-31 | (m) | $544.79M | $110.59M | (m) | $387.30M | $227.32M | (m) |
| 2015-12-31 | (m) | $595.13M | $98.89M | (m) | $411.42M | $214.38M | (m) |
| 2015-09-30 | (m) | $593.41M | $123.30M | (m) | $390.54M | $225.54M | (m) |
| 2015-06-30 | (m) | $579.54M | $149.31M | (m) | $402.40M | $223.28M | (m) |
| 2015-03-31 | (m) | $637.70M | $75.36M | (m) | $382.38M | $218.66M | (m) |
| 2014-12-31 | (m) | $678.89M | $85.26M | (m) | $435.65M | $204.53M | (m) |
| 2014-09-30 | (m) | $650.88M | $126.31M | (m) | $410.90M | $219.71M | (m) |
| 2014-06-30 | (m) | $640.38M | $111.01M | (m) | $427.50M | $224.45M | (m) |
| 2014-03-31 | (m) | $509.19M | $115.80M | (m) | $425.16M | $224.42M | (m) |
| 2013-12-31 | (m) | $564.19M | $111.87M | (m) | $466.70M | $210.41M | (m) |
| 2013-09-30 | (m) | $538.98M | $92.22M | (m) | $402.71M | $219.18M | (m) |
| 2013-06-30 | (m) | $509.03M | $120.22M | (m) | $418.03M | $203.29M | (m) |
| 2013-03-31 | (m) | $478.30M | $93.21M | (m) | $410.65M | $199.57M | (m) |
| 2012-12-31 | (m) | $562.68M | $101.70M | (m) | $437.39M | $198.94M | (m) |
| 2012-09-30 | (m) | $555.24M | $105.37M | (m) | $406.57M | $214.89M | (m) |
| 2012-06-30 | (m) | $523.00M | $134.77M | (m) | $397.24M | $217.23M | (m) |
| 2012-03-31 | (m) | $525.42M | $156.19M | (m) | $389.12M | $238.18M | (m) |
| 2011-12-31 | (m) | $609.84M | $235.60M | (m) | $425.15M | $241.42M | (m) |
| 2011-09-30 | (m) | $617.28M | $262.47M | (m) | $398.40M | $265.35M | (m) |
| 2011-06-30 | (m) | $566.00M | $328.76M | (m) | $382.09M | $268.15M | (m) |
| 2011-03-31 | (m) | $524.41M | $388.10M | (m) | $365.58M | $247.19M | (m) |
| 2010-12-31 | (m) | $542.19M | $447.58M | (m) | $368.94M | $217.10M | (m) |
| 2010-09-30 | (m) | $606.02M | $142.88M | (m) | $331.95M | $215.32M | (m) |
| 2010-06-30 | (m) | $528.97M | $111.59M | (m) | $310.07M | $185.17M | (m) |
| 2010-03-31 | (m) | (m) | $85.88M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $494.68M | $85.03M | (m) | $313.00M | $168.04M | (m) |
| 2009-09-30 | (m) | (m) | $113.95M | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | $119.73M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $78.07M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $81.22M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |